Coumestrol-Induced Ferroptosis Suppresses RA Synoviocyte Act
2026-05-15
This study demonstrates that coumestrol, a natural phytoestrogen, induces ferroptosis in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis (RA) patients by stabilizing mitochondrial PMAIP1 through inhibition of TRIM3-mediated degradation. The findings highlight a novel therapeutic angle for RA by leveraging regulated cell death to limit synoviocyte-driven inflammation and hyperproliferation.
Gastrin I: Optimizing Human Gastrointestinal Physiology Stud
2026-05-15
Harness the specificity of human Gastrin I peptide to dissect gastric acid secretion pathways in advanced in vitro systems. This guide translates recent organoid advances and experimental workflows into actionable protocols and troubleshooting strategies, empowering researchers with reproducible, high-fidelity models for gastrointestinal disorder research.
S63845 MCL1 Inhibitor: Redefining Apoptosis for Translationa
2026-05-14
This thought-leadership article explores the mechanistic depth and translational value of the S63845 MCL1 inhibitor, spotlighting its role as a mitochondrial apoptotic pathway activator in hematological cancer research. Integrating recent discoveries in apoptosis modulation—including insights from bacterial evasion strategies—the discussion offers strategic guidance for researchers aiming to leverage S63845 in advanced models and combination approaches. Practical protocol parameters and a visionary outlook on future translational impact are included.
CDK4/6 and BET Inhibitors Synergize Against Pancreatic Cance
2026-05-14
Gu et al. demonstrate that combined CDK4/6 and BET inhibition synergistically suppresses pancreatic tumor growth and reverses EMT by regulating the GSK3β-mediated Wnt/β-catenin pathway. This mechanistic insight informs future therapeutic strategies and highlights the importance of robust cell proliferation assays in tumor biology research.
Prochlorperazine: Dopamine D2 Receptor Antagonist in Researc
2026-05-13
Prochlorperazine is redefining cancer and antiviral research with its multi-receptor antagonism and robust antiemetic profile. This guide translates bench-to-bedside workflows, integrating protocol enhancements and troubleshooting strategies for reproducible results.
Cell Integrity Sets Ploidy Limits in Budding Yeast: New Insi
2026-05-13
This study uncovers how cell surface integrity fundamentally restricts the maximum ploidy attainable by budding yeast, revealing that physical stress on the cell membrane, rather than genetic constraints alone, sets an upper bound for genome duplication. The findings bridge genome biology with membrane physiology, providing a new perspective for research into polyploidy, cell mechanics, and antifungal strategies.
Proteinase K (K1037): Mechanisms, Specificity, and Workflow
2026-05-12
Explore how Proteinase K, a broad-spectrum serine protease, enables precise protein hydrolysis and DNA integrity preservation. This article offers an in-depth look at the enzyme's mechanism, selectivity, and advanced assay implications, uniquely bridging scientific findings with practical laboratory decisions.
Novobiocin: Aminocoumarin Antibiotic for Antiparasitic Workf
2026-05-12
Novobiocin stands out as a versatile aminocoumarin antibiotic, offering targeted inhibition of DNA gyrase and Hsp90 with proven efficacy against pathogens like Toxoplasma gondii. Recent research and practical experience converge to inform optimized experimental protocols, enhanced selectivity, and strategic troubleshooting for antiparasitic, antibacterial, and antiviral applications.
Ziprasidone Targets GOT1 to Reprogram Glutamine Metabolism i
2026-05-11
This study identifies ziprasidone as a non-competitive inhibitor of GOT1, demonstrating its ability to disrupt glutamine metabolism and suppress pancreatic ductal adenocarcinoma (PDAC) cell proliferation both in vitro and in vivo. The findings highlight GOT1 as a promising therapeutic target in PDAC and establish a mechanistic link between metabolic reprogramming and antitumor efficacy.
SR 11302: Applied Workflows for AP-1 Transcription Factor In
2026-05-11
SR 11302 stands out as a selective AP-1 transcription factor inhibitor, enabling precise dissection of oncogenic and immune pathways without retinoid-related confounders. This article delivers actionable protocols, troubleshooting support, and translational guidance for maximizing SR 11302’s impact in cancer research assays.
Nutlin-3a and the MDM2-p53 Axis: Mechanistic Insights for Tr
2026-05-10
Discover how Nutlin-3a, a leading MDM2 inhibitor, uniquely illuminates the molecular intricacies of p53 pathway activation and apoptosis in cancer research. This in-depth analysis explores advanced assay parameters and integrates new insights from lipid metabolism and glioblastoma biology.
Brain-to-Spinal Circuits Regulate Mechanical Allodynia Later
2026-05-09
This study delineates a contralateral brain-to-spinal neural circuit that modulates the laterality and persistence of mechanical allodynia in mice. The findings clarify how hypothalamic dynorphin-spinal κ-opioid receptor signaling gates pain hypersensitivity, providing new avenues for targeted pain modulation research.
Streptavidin – Cy5: Redefining Biotin Detection in Oncology
2026-05-09
This article bridges mechanistic insight with translational strategy, showcasing how APExBIO’s Streptavidin – Cy5 empowers researchers to unravel complex molecular mechanisms in breast cancer and beyond. By synthesizing evidence from recent USP42 studies with advanced fluorescent biotin detection methodologies, we clarify the reagent’s pivotal role in driving reproducibility and sensitivity in immunohistochemistry, immunofluorescence, and flow cytometry workflows.
5-Methyl-CTP: Precision Engineering of mRNA Synthesis and Va
2026-05-08
Explore how 5-Methyl-CTP enables advanced mRNA synthesis with enhanced stability and translation efficiency. This article uniquely dissects core mechanistic innovations and practical assay implications, highlighting distinct advances in mRNA vaccine technology.
Recombinant Human Growth Hormone (GH): Reliable Assay Soluti
2026-05-07
Laboratories face persistent challenges in cell proliferation, viability, and signaling pathway assays due to variability in growth hormone reagents. This article explores how Recombinant Human Growth Hormone (GH) (SKU P1223) addresses these issues with validated performance, high purity, and robust activity. Evidence-based scenarios guide researchers toward reproducible, data-driven workflows using APExBIO's recombinant somatotropin.
466 records 19/32 page Previous Next First page 上5页 1617181920 下5页 Last page